"Mu oogun yi pelu ounje. Pari gbogbo ọjọ meje lati dena atako oogun."
Take with food. Complete the full 7-day course to prevent resistance.
Illustrative model output — see live interactive demo →
Existing solutions have failed to scale because they don't address the last mile of patient decision-making in low-resource, low-connectivity environments — leaving a structural gap worth closing.
Patients default to informal vendors with limited clinical training — a trust vacuum with no incumbent solving it at scale.
Roughly one in six drugs in circulation. These fuel antimicrobial resistance and drive preventable mortality.
A structural scarcity that no headcount-based intervention can close — but software can.
Smartphone penetration across Sub-Saharan Africa has crossed the threshold needed to deliver software-based clinical guidance directly to the point of consumption — for the first time, at population scale.
Four integrated capabilities transform any smartphone into a verified, multilingual point of medication intelligence — engineered for the connectivity realities of the region it serves.
Computer-vision scanning analyzes holograms, serial numbers, and packaging security features against a proprietary manufacturer-verified database. Trust Score returned in seconds.
Dosage instructions and side-effect warnings delivered in Yoruba, Hausa, Igbo, and Pidgin — clinical guidance that's actually understood, not just translated.
"Sync-and-Save" keeps interaction databases, adherence schedules, and core guidance fully functional without cellular connectivity — built for where it will actually be used.
Real-time drug-drug and drug-food interaction alerts, plus smart nudges to complete antibiotic courses — protecting individual patients and slowing antimicrobial resistance.
RxLoop is free at the point of basic use — the business model monetizes the institutions and data layers built on top of population-scale trust, not the patient's access to safety.
Licensed pharmacies, hospital groups, and clinic networks subscribe to dashboards with real-time visibility into patient adherence, medication history, and population-level insights.
Core AI guidance stays free. Users can escalate instantly to licensed pharmacists for video or audio consultations at a transparent flat fee — high-margin, on-demand revenue.
Anonymized, aggregated data on drug usage patterns, counterfeit hotspots, and adherence behaviors licensed to NGOs, ministries of health, and global health organizations.
Free-to-patient access removes the only friction that matters at the last mile — willingness to use the product at all. Every additional user makes the counterfeit-detection database, the language models, and the population-health data more valuable to the institutions paying for it. Growth on one side of the platform compounds revenue on the other.
Computer-vision models trained on manufacturer packaging, holograms, and batch-code databases.
NLP models fine-tuned for Yoruba, Hausa, Igbo, and Pidgin clinical communication.
Offline-first "Sync-and-Save" data architecture for low-connectivity environments.
Lightweight mobile client designed for low-spec Android devices at minimal data cost.
Subscribe to adherence dashboards, license aggregate population-health data, or integrate RxLoop's verification layer into your existing distribution network.
Discuss a partnershipFree guidance in your language, instant counterfeit checks before you take a single pill, and reminders that help you finish every course safely.
See the demoA deliberate, phased approach to building sustainable pharmaceutical infrastructure across the continent.
Launch in Lagos urban hubs and select rural clusters in Northern Nigeria. Focus on 40 million smartphone users. Deep NLP training for major local languages.
Scale to Ghana and Côte d'Ivoire. Adapt NLP models for additional dialects. Strengthen B2B partnerships with regional pharmacy chains and health systems.
Pan-African rollout. Capture meaningful share of the $65 billion African pharmaceutical market. Become the default layer of medication-safety infrastructure.
RxLoop is strategically positioned to attract impact-focused capital from the world's leading global-health and innovation funders.
Resonates with the mandates of the Bill & Melinda Gates Foundation, Grand Challenges Canada, and the Tony Elumelu Foundation — organizations focused on scalable, culturally intelligent solutions that create both health impact and economic opportunity.
Co-Founder & Visionary
Nathaniel co-founded RxLoop to close one of healthcare's most dangerous gaps: the moment between receiving a prescription and safely completing treatment. He believes frontier AI, when built with cultural intelligence and radical accessibility, can protect millions of lives across the continent.
The Nigeria pilot launches in late 2026. Explore the interactive demo, then join the early-access list for investors, partners, and healthcare professionals shaping the rollout.